However, the normal lung fibroblast cell lines, MRC-5 and HFL1 were both significantly radiosensitized following the knockdown of SRP72 (Fig. 2A, B), suggesting that targeting SRP72 in cancer patients is unlikely to improve the therapeutic window. Here, SRP72 is linked to cancer.